Donald Corson
About Donald Corson
Donald Corson serves as the Vice President of CMC at Day One Biopharmaceuticals, bringing extensive experience in pharmaceutical development and solid state chemistry. He holds a Ph.D. in Chemistry from the University of California, Davis, and has previously held senior roles at Array BioPharma, Pfizer, and Medivation.
Current Role at Day One Biopharmaceuticals
Donald Corson serves as the Vice President of CMC at Day One Biopharmaceuticals. He has held this position since 2022, contributing to the company's efforts in drug development and manufacturing. His role involves overseeing chemistry, manufacturing, and controls, ensuring compliance with regulatory standards and facilitating the development of pharmaceutical products.
Previous Experience at Array BioPharma
Prior to his current role, Corson worked at Array BioPharma for a total of nine years, from 2006 to 2015. During his tenure, he held positions as Senior Research Scientist and later as Senior Group Leader in Pharmaceutics and Formulation Development. His work focused on developing formulations and processes for drug products, contributing to the advancement of Array BioPharma's portfolio.
Experience at Pfizer and Medivation
Corson served as the Director of Drug Product Development at Pfizer from 2016 to 2022 in the San Francisco Bay Area. He also briefly worked at Medivation as Director of Pharmaceutical Technology for seven months in 2016. In these roles, he was responsible for leading teams in the development of pharmaceutical products and ensuring adherence to industry standards.
Educational Background in Chemistry
Donald Corson earned a Bachelor of Science in Chemistry from the University of California, Los Angeles. He furthered his education by obtaining a Ph.D. in Chemistry from the University of California, Davis, where he specialized in Organic Chemistry. His academic background provides a strong foundation for his expertise in solid-state chemistry and good laboratory practices.
Expertise in Pharmaceutical Development
Corson possesses extensive expertise in solid-state chemistry, validation, and regulatory CMC. His knowledge in good laboratory practices (GLP) enhances his ability to lead teams in pharmaceutical development. His experience across various organizations has equipped him with the skills necessary to navigate the complexities of drug product development and regulatory compliance.